In budding yeast cells, nutrient repletion induces rapid exit from quiescence and entry into a round of growth and division. The G1 cyclin CLN3 is one of the earliest genes activated in response to nutrient repletion. Subsequent to its activation, hundreds of cellcycle genes can then be expressed, including the cyclins CLN1/2 and CLB5/6. Although much is known regarding how CLN3 functions to activate downstream targets, the mechanism through which nutrients activate CLN3 transcription in the first place remains poorly understood. Here we show that a central metabolite of glucose catabolism, acetyl-CoA, induces CLN3 transcription by promoting the acetylation of histones present in its regulatory region. Increased rates of acetyl-CoA synthesis enable the Gcn5p-containing Spt-AdaGcn5-acetyltransferase transcriptional coactivator complex to catalyze histone acetylation at the CLN3 locus alongside ribosomal and other growth genes to promote entry into the cell division cycle.
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growth control | metabolism | epigenetics T he most basic building blocks of biological organisms are smallmolecule metabolites. In recent years, there has been renewed interest in understanding how the fundamental processes of cell growth and proliferation are coordinated with cellular metabolism. Nutrient-starved yeast cells arrest in a quiescent, or G0, phase of the cell division cycle. Addition of nutrients stimulates exit from the G0 and transition into the G1 phase, and then ∼800 genes are periodically transcribed as a function of the cell cycle (1, 2) . CLN3 is observed to be one of the earliest genes transcribed within this set (1) (2) (3) . Cln3p regulates G1 length by coordinating growth and division and may influence cell size when passing Start, the point at which cells commit to division (4) (5) (6) (7) . In cln3Δ mutants, cells become larger and stay in the G1 phase longer, resulting in decreased growth and budding rates compared with WT (8, 9) (Fig. S1 ). Following CLN3 activation, the G1 transcription complexes Swi4p-Swi6p (SBF) and Mbp1-Swi6p (MBF) can be activated by CLN3/CDC28-catalyzed phosphorylation of the SBF inhibitor Whi5p (10) (11) (12) , and other unknown mechanisms, to enable transcription of over 200 downstream cell-cycle genes (13) , including CLN1/2 and CLB5/6. Cln1p and Cln2p can then further enhance SBF-and MBF-dependent G1 transcription through positive feedback mechanisms (14) (15) (16) (17) (18) (19) (20) .
Although many studies have focused on the mechanisms by which Cln3p regulates G1 transcription, the mechanisms that lead to transcriptional activation of CLN3 itself still remain unresolved. Since the discovery of CLN3 more than 20 y ago (6, 7) , the gene and its encoded protein have been reported to be regulated at multiple levels. At the transcriptional level, CLN3 is activated by glucose (21, 22) , which is reportedly mediated by Azf1p, a zinc-finger transcription factor (23) . Following transcription, CLN3 mRNA availability is regulated by a RNAbinding protein, Whi3p (24) . At the translational level, CLN3 is regulated by TOR (target of rapamycin) and cAMP-protein kinase A (PKA) pathways (25, 26) and repressed under various stress conditions (27, 28) . Cln3p is thought to be a very unstable protein and subjected to ubiquitin-dependent proteolysis (29) (30) (31) (32) . Finally, Cln3p protein localization has been reported to be regulated by molecular chaperones Ydj1p and Whi3p (33, 34) . Cln3p also has a nuclear localization sequence on its C terminus for nuclear import (35) .
We have been using the yeast metabolic cycle (YMC) to investigate the mechanisms that link cell growth and division to metabolism (36) . In the YMC, a highly synchronized cell population undergoes robust oscillations in oxygen consumption and metabolism that are coupled to the cell cycle, during continuous glucose-limited growth (37, 38) . Microarray analysis of gene expression during the YMC has revealed that over half of all yeast genes are periodically expressed according to a specified logic. The YMC can be divided into three phases based on gene expression clustering: oxidative (OX), reductive building (RB), and reductive charging (RC) (37) . In the OX phase, the vast majority of cellular growth genes are activated during a period of increased oxygen consumption. These include ribosomal protein (RP) and ribosome biogenesis (ribi) genes, amino acid biosynthetic genes, and numerous genes involved in increasing translational capacity. In the RB phase, the rate of oxygen consumption begins to decrease and a fraction of the cell population enters cell division. In this phase, many genes with roles in cell division are expressed, such as those encoding histone proteins, spindle pole body components, and proteins required for DNA replication. In the RC phase, a large cohort of genes associated with stress, survival, and stationary phase are induced. These expression data have also enabled the high-resolution timing of cell-cycle-regulated transcripts to a resolution of ∼2-3 min (3). The vast majority of "goldstandard" cell-cycle genes, including all of the cyclins, are periodic and transcribed in their expected order in this YMC dataset (3) . The accurate timing of cyclin and cell-cycle gene expression as viewed in the YMC indicates that it faithfully recapitulates the order of events associated with cell-cycle entry and progression. In this study, we used both the YMC and traditional batch cultures to dissect the mechanism by which the transcription of the key G1 cyclin CLN3 is activated by metabolic cues to promote cell-cycle entry.
Results
Histone H3 Is Extensively Acetylated at the Promoter Region of CLN3 upon Its Activation. In a recent study, we uncovered an important mechanism by which cellular growth genes are regulated in tune with metabolism. The acetylation of histones on multiple sites on H3 and H4 increases substantially during the OX growth phase of the YMC, precisely when intracellular levels of the metabolite acetyl-CoA increase (36) . Subsequent ChIP-sequencing analysis revealed that these acetylated histones were present almost exclusively at a set of over ∼1,000 OX-phase genes that are collectively rate-limiting for cell growth. These data reveal that acetyl-CoA induces the acetylation of histones at these growth genes to enable cell growth and proliferation (36, 39) .
Interestingly, we observed that CLN3 belongs to this group of OX-phase growth genes (Fig. 1A) . CLN3 is one of the earliest expressed genes specifically associated with the cell cycle (1) (2) (3) 37) . Transcript levels of CLN3 peak sharply in the OX phase along with ribosomal and other growth genes (Figs. S2 and S3). CLN1 and CLN2 expression immediately follow that of CLN3 in the YMC (Fig. 1A) . These data are consistent with previous reports showing that CLN3 is expressed rapidly in response to fresh nutrients and subsequently activates the other G1 cyclins, CLN1 and CLN2 (40) (41) (42) . We therefore hypothesized that CLN3 transcription might be similarly driven by the acetyl-CoA-induced acetylation of histones present in its regulatory region.
To quantitate histone acetylation at the CLN3 locus as cells transitioned into the OX growth phase of the YMC, we performed ChIP using antibodies that recognize specific acetylated sites on histone H3. We observed a significant increase in acetylation on multiple sites (H3K9, H3K14, H3K18, and H3K23) during a time window precisely coinciding with the peak in CLN3 mRNA levels (Fig. 1) . The acetylated histones were detected in a region corresponding to the CLN3 promoter proximal to a previously identified glucose responsive element (GRE) (21, 23) . These histones became rapidly deacetylated as cells proceeded further into the OX growth phase (Fig. 1B) .
We next tested whether the dynamic acetylation of histones at the CLN3 locus could also be observed in a batch culture model in which cells exit quiescence and rapidly enter growth upon nutrient repletion ( Fig. 2A) . Following addition of fresh media containing glucose as the carbon source, we observed a substantial increase of histone acetylation on multiple sites in the same CLN3 promoter region within 10 min (Fig. 2B) , coinciding with the timing of CLN3 mRNA induction (Fig. 3B) . Taken together, these data indicate that histones on nucleosomes present at the upstream CLN3 regulatory region are dynamically acetylated as yeast cells transition from a quiescent state into growth.
Acetyl-CoA Induces CLN3 Transcription via the Gcn5p-Containing SptAda-Gcn5-acetyltransferase Transcriptional Coactivator. Our observations thus far are entirely consistent with previous studies showing that glucose is a potent inducer of CLN3 transcription (22) . However, none of the well-known glucose or nutrientsignaling pathways, including cAMP-PKA, TOR, and various glucose transporters, seems to be required for glucose-induced CLN3 transcription (9, 22, 43) . In contrast, the inhibition of glycolysis compromises glucose-induced CLN3 transcription, suggesting a downstream metabolite of glucose could be mediating its effects (9, 22) .
Recently, we observed that acetyl-CoA is a key metabolite of glucose and carbon sources that induces growth entry (36) . AcetylCoA not only fuels the tricarboxylic acid cycle for ATP synthesis but is also used to synthesize fatty acids, sterols, and amino acids. Several simple carbon sources including ethanol, acetaldehyde, and acetate, each of which must be converted to acetyl-CoA for its assimilation (Fig. 3A) , can effectively induce cycling cells to exit the quiescentlike RC phase and immediately enter the OX growth phase (36) . The increased acetyl-CoA production upon entry into growth is sensed by the Gcn5p-containing Spt-Ada-Gcn5-acetyltransferase (SAGA) complex (44) and enables it to catalyze histone acetylation specifically at growth genes, the majority of which are transcribed during the OX phase of the YMC (36) . Because CLN3 transcription occurs during the OX phase alongside other growth genes and is coincident with a spike in acetyl-CoA levels and histone acetylation in its regulatory region, acetyl-CoA may also represent the key metabolic driver of CLN3 transcription.
To investigate a possible role for acetyl-CoA in the regulation of CLN3 transcription, we tested whether acetate can induce CLN3 transcription in quiescent cells. Stationary-phase cells were added to fresh media containing either YPD, glucose alone, or acetate alone, and CLN3 transcription was monitored over several time points. Strikingly, CLN3 transcription was induced in response to all three conditions with similar kinetics (Fig. 3B ). To rule out the possibility that CLN3 transcription by acetate Fig. 1 . CLN3 transcription during the YMC is accompanied by histone acetylation in its promoter region. (A) CLN3 transcript levels peak before CLN1 and CLN2 in the OX phase. Relative mRNA abundance (Left) of CLN3, CLN1, and CLN2 at 36 time points across three consecutive metabolic cycles (Right). Expression data are derived from the YMC microarray dataset (37) . Each time point corresponds to ∼25 min. (B) Histone H3 acetylation at the CLN3 locus correlates tightly with CLN3 transcription. Histone acetylation was measured by ChIP with six primer pairs designed to span sequences upstream of the CLN3 gene and its ORF. The glucose responsive element (GRE) is marked (21) . Samples for ChIP were collected at the four time points, 1-4, each ∼5 min apart. Histone H3 acetylation signal was normalized to total histone H3 binding and expressed as relative occupancy. Mean ± SD, n = 3. repletion might be due to osmotic or ionic stress, CLN3 induction was measured following repletion of other anionic salts such as sulfate, carbonate, or citrate, as well as water alone. Only acetate could potently induce CLN3 transcription (Fig. 3C ). As expected, the induction of CLN3 transcription by acetate depends on functional acetyl-CoA synthetase enzymes (Fig. 3D) . Because there is no other fate for acetate except its conversion to acetylCoA via the acetyl-CoA synthetase enzymes, these data suggest that acetyl-CoA derived from either glucose or acetate is sufficient to induce CLN3 transcription. However, acetyl-CoA derived from acetate can be used for gluconeogenesis through the glyoxylate pathway (Fig. 3A) , thereby potentially contributing a source of glucose that could stimulate CLN3 transcription through some as-yet-unidentified glucose-specific pathway. To rule out this possibility, we tested whether acetate could still induce CLN3 transcription in a icl1Δ mutant lacking the glyoxylate pathway (45) . CLN3 transcription was not compromised in this mutant, indicating that acetyl-CoA, and not glucose, is the key metabolite sufficient to activate CLN3 transcription (Fig. 3F) .
We next tested whether acetyl-CoA-induced CLN3 transcription is likewise dependent on the Gcn5p acetyltransferase enzyme present within SAGA that catalyzes histone acetylation at growth genes (36) . We assayed CLN3 transcription following rich medium repletion in a gcn5Δ or gcn5 E173Q mutant that is catalytically inactive (46) . In addition, we tested the sgf73Δ mutant, which lacks an important subunit of SAGA that is dynamically acetylated in response to acetyl-CoA (36). Sgf73p is important for the histone acetyltransferase activity of SAGA and its recruitment to DNA (36, 47) . CLN3 induction was significantly compromised in each of these mutants, revealing the importance of Gcn5p and components of SAGA for activation of this gene (Fig. 3E) . In gcn5 mutants, CLN3 induction was virtually eliminated, whereas the sgf73Δ mutant could still induce CLN3, albeit with slower kinetics. Moreover, glucose or acetate alone could no longer induce CLN3 transcription in the gcn5 E173Q mutant (Fig. 3F) , and the acetate-induced histone acetylation in WT quiescent cells was abolished in the gcn5 E173Q mutant (Fig. S4) . These data clearly demonstrate that the effects of acetyl-CoA on CLN3 induction are dependent on the acetyltransferase activity of Gcn5p, which consumes acetyl-CoA as a substrate.
To further investigate the possibility that Gcn5p activity is modulated by levels of acetyl-CoA, we constructed a gcn5 A190T mutant that was previously reported to have higher acetyl-CoA binding affinity in vitro (48) . If this change to the enzyme is recapitulated in vivo, CLN3 transcription in this mutant can be predicted to be more responsive to acetate repletion than WT. However, CLN3 induction in this gcn5 A190T mutant was suboptimal at multiple acetate concentrations tested, (Fig. S5A) . Furthermore, higher concentrations of acetate were needed to induce gcn5 A190T cells to enter the OX growth phase of the YMC, suggesting that this mutant is actually less responsive to acetate than WT (Fig. S5B) . These phenotypes are consistent with our previous observation that the gcn5 A190T mutant is defective for growth on acetate as a carbon source (36) . Nonetheless, these data suggest the affinity of the Gcn5p acetyltransferase enzyme for acetyl-CoA can be neither too high nor too low, and that the WT enzyme has been optimized to respond to a particular threshold of acetyl-CoA levels in vivo. The observation that a catalytically inactive mutant of Gcn5p is defective in CLN3 induction, coupled with the observation that a mutation of Gcn5p that purportedly increases its affinity for acetyl-CoA in vitro is also suboptimal for CLN3 induction, argues that the activity of this acetyltransferase enzyme can be sensitive to acetyl-CoA fluctuations in vivo.
We also tested other known histone acetyltransferases (HATs) for possible contributions to CLN3 transcription, including ESA1, the catalytic subunit of the NuA4 complex, SAS2, SAS3, and HPA2. None of these other HATs had any effect on CLN3 transcription following nutrient repletion (Fig. 3 G and H) , indicating that Gcn5p-containing SAGA is the major acetyltransferase that catalyzes histone acetylation at the CLN3 locus to activate gene transcription. CLN3 transcription in batch culture was assayed by real-time quantitative PCR at indicated times following exposure of quiescent cells to fresh YPD medium, 2% glucose alone, or 10 mM acetate alone. CLN3 mRNA levels were normalized to ACT1 mRNA levels and expressed as CLN3 expression relative to ACT1. Mean ± SD, n = 3. (C) CLN3 transcription is specifically induced by acetate. CLN3 transcription was measured as above in WT following repletion with water, 0.1 mM sodium sulfate, sodium carbonate, sodium citrate, or sodium acetate. Mean ± SD, n = 3. (D) Acetate-induced CLN3 transcription requires intact acetyl-CoA synthetase activity. CLN3 transcription was measured as above in the temperature-sensitive mutant acs1Δ, acs2-ts at permissive and nonpermissive temperatures upon repletion with 0.1 mM acetate. Mean ± SD, n = 3. The temperature-sensitive growth defect of this strain on YPD is shown (Inset). (E) CLN3 transcription is dependent on Gcn5p and components of SAGA. CLN3 transcription was measured as above in WT, gcn5 E173Q (catalytically inactive), gcn5Δ, and sgf73Δ strains following repletion with YPD. Mean ± SD, n = 3. (F) Acetyl-CoA-induced transcription of CLN3 is dependent on the acetyltransferase activity of Gcn5p. CLN3 transcription was measured as above in WT, icl1Δ, and gcn5 E173Q strains repleted with either 2% glucose or 10 mM acetate. icl1Δ mutants cannot convert acetyl-CoA to glucose. Mean ± SD, n = 3. (G) CLN3 transcription is not dependent on the Esa1p-containing NuA4 H4 acetyltransferase complex. CLN3 transcription was measured as above in WT and the esa1-ts mutant, following repletion with YPD at either the permissive (28°C) or nonpermissive temperature (40°C). (H) CLN3 transcription is not dependent on other acetyltransferases. CLN3 transcription was measured as above in WT, sas2Δ, sas3Δ, and hpa2Δ strains following repletion with YPD medium. Mean ± SD, n = 3.
To further investigate the regulation of CLN3 transcription by SAGA, we examined whether SAGA is recruited to the CLN3 promoter within the time frame of its transcription. Because CLN3 transcription was observed in as early as 3 min immediately after nutrient repletion (Fig. S3) , we tested for SAGA binding within this short time interval. SAGA binding was assessed by ChIP of strains expressing a flag epitope-tagged version of Spt7p, a scaffold protein important for integrity of the complex (49) . SAGA binding at the CLN3 regulatory region was observed in as early as 1 min after glucose repletion (Fig. 4) . SAGA can auto-acetylate itself on several subunits (36, 50) , most notably on Sgf73p, which may mediate its recruitment to growth genes in response to acetyl-CoA (36) . To test whether acetylation of SAGA might aid its recruitment to CLN3, we assayed SAGA binding in gcn5 E173Q, gcn5Δ, and sgf73Δ mutants following nutrient repletion. SAGA recruitment to the CLN3 promoter, as well as ribosomal subunit gene promoters (RPS11B and RPL33B), was compromised by the absence of Gcn5p acetyltransferase activity (Fig. 4) . Moreover, in the sgf73Δ mutant, SAGA recruitment to CLN3 and ribosomal genes was largely undetectable (Fig. 4) , which was not due to lower amounts of Spt7p in the mutant whole-cell lysates or immunoprecipitates (Fig. S6) , suggesting that Sgf73p plays a key role in facilitating SAGA to bind growth gene targets. Although SAGA recruitment in the sgf73Δ mutant as assayed by Spt7p ChIP was not detectable over a 60-min time period following glucose repletion (Fig. S6) , CLN3 induction could still occur, but at much slower rates (Fig. 3E) .
We speculated that other chromatin-modifying complexes might function to maintain the CLN3 promoter region permissive for continued transcription. Because the Swi/Snf chromatin remodeling complex has been linked to SAGA and may have functions redundant with SAGA (51-53), we tested whether the Swi/Snf complex might play a role in CLN3 transcription. We observed Snf2p binding to the CLN3 promoter region within 3 min following nutrient repletion, consistent with the time frame of SAGA binding and CLN3 induction (Fig. S7) . Furthermore, CLN3 induction was compromised in the snf2Δ mutant, suggesting that the Swi/Snf complex is required to attain maximal levels of CLN3 transcription (Fig. S7 ).
Rap1p and Fhl1p Are Transcription Factors That May Regulate CLN3
Transcription. The SAGA transcriptional coactivator reportedly cannot bind DNA directly, so it must be recruited to its targets with the aid of particular transcription factors (54) . The zinc-finger transcription factor Azf1p was previously reported to activate glucose-induced CLN3 transcription by binding the GRE elements in its promoter (21, 23) . Using an azf1Δ mutant strain, we confirmed the role for Azf1p in glucose-induced CLN3 transcription and further showed its requirement for acetate-induced CLN3 transcription (Fig. S8A) . However, we were not able to observe significant Azf1p binding to the CLN3 locus following nutrient repletion after many exhaustive trials. Consistent with our results, Azf1p binding was not observed at the CLN3 promoter in a genome-wide survey of transcription factor binding (55) . We then assayed Azf1p binding to the CLN3 promoter using the YMC where cells synchronously transition between different metabolic states. Surprisingly, Azf1p binding to the CLN3 regulatory region was observed in the RB phase, whereas CLN3 transcript levels peak much earlier in the OX phase (Fig. S8B) . A transcription factor that mediates the recruitment of SAGA to the CLN3 locus would be expected to bind specifically during the OX phase. Thus, how Azf1p contributes to the regulation of CLN3 transcription may be more complicated than expected and requires further investigation.
Mcm1p is another transcription factor reported to mediate CLN3 transcription in a cell-cycle-dependent manner (56) (57) (58) (59) . We tested the binding of Mcm1p to the CLN3 promoter across the YMC. Surprisingly, Mcm1p binding at the CLN3 promoter was observed in the RB phase and did not correlate with the temporal window of active CLN3 transcription (Fig. S9B) , although we observed correlation of Mcm1p binding and CLN3 transcription in batch culture (Fig. S9A) . The same disconnect between the timing of Mcm1p binding and transcription was observed for two ribosomal subunit genes, RPS11B and RPL33B (Fig.  S9B) . Moreover, a mcm1-ts mutant did not compromise CLN3 transcription (21) . As with Azf1p, a direct role for Mcm1p in activating CLN3 transcription remains uncertain. Because Mcm1p can serve as either a transcriptional activator or repressor, it may play a repressive role at CLN3 and ribosomal genes.
To determine whether other transcription factors might regulate CLN3, we mined a list of possible candidates that have been reported to bind its regulatory region using Yeast Search for Transcriptional Regulators And Consensus Tracking (YEASTRACT) (60) . We constructed individual deletion strains for nonessential transcription Fig. 4 . Recruitment of SAGA to the CLN3 promoter region depends on its acetyltransferase activity. SAGA binding at the CLN3 promoter was assayed by ChIP in WT, gcn5 E173Q, gcn5Δ, and sgf73Δ strains expressing SPT7-FLAG at 0, 1, 3, and 5 min immediately after repletion of quiescent cells with 2% glucose. Spt7p binding was normalized to the input DNA. Spt7p binding at promoters of ribosomal genes RPS11B and RPL33B is shown as control. Mean ± SD, n = 3. Spt7p binding spanned a larger region compared with acetylated histones (Figs. 1 and 2) . factors on this list. None of these except Azf1p displayed a compromising effect on glucose-induced CLN3 transcription (Fig. S8A) . Besides Mcm1p, Rap1p and Fhl1p are two essential transcription factors that have been reported to bind the CLN3 regulatory region in genome-wide studies (61) (62) (63) (64) . Rap1p and Fhl1p in complex with other transcription factors are known to regulate ribosomal gene expression (65) (66) (67) (68) . In both the YMC and batch cultures, we observed the tight coregulation of CLN3 transcription with ribosomal subunit gene transcription (Figs. S2 and S3 ). We then observed that both Rap1p and Fhl1p bound the CLN3 promoter region immediately following nutrient repletion (Fig. 5A and Fig. S9A ). In the YMC, in contrast to Azf1p and Mcm1p, Rap1p and Fhl1p bound the CLN3 regulatory region as well as RPS11B and RPL33B precisely in the OX growth phase, which is the time of active CLN3 transcription (Fig. 5B and Fig. S9B ). Furthermore, we tested a temperature-sensitive mutant, rap1-ts, for its ability to induce CLN3 expression. CLN3 transcription in this mutant was compromised only at the nonpermissive temperature, further suggestive of an active role for Rap1p in CLN3 transcription (Fig. 5C) . Thus, our findings suggest that Rap1p, and possibly Fhl1p, may represent the transcription factors that together with SAGA induce the transcription of CLN3 and ribosomal genes in response to acetyl-CoA.
Discussion
How cell growth and division are coordinated with metabolism and the metabolic state of a cell has remained a critical unresolved question in the cell-cycle field. Although many previous studies of the yeast cell cycle have focused on transcriptional events downstream of the G1 cyclin CLN3, it has remained unclear what drives the transcription of CLN3 in the first place upon exit from quiescence to set subsequent events of the cell cycle in motion. CLN3 has been proposed to be subjected to multiple forms of regulation, at the transcriptional, posttranscriptional, and posttranslational levels. Moreover, although glucose is known to be a potent inducer of CLN3 transcription (21, 22) , how the glucose signal might be relayed to the transcriptional machinery to activate the CLN3 gene has remained poorly understood.
In this study, we provide evidence that acetyl-CoA is most likely the key metabolite of glucose and carbon sources that drives the transcription of CLN3, thereby linking cellular metabolism to a critical regulator of cell-cycle progression. As revealed by the high synchrony and temporal resolution offered by the YMC, CLN3 is coexpressed along with ribosomal and other growth genes as cells exit the quiescent-like RC phase and transition into the OX growth phase (Fig. S2) . We previously discovered that acetylCoA induces the acetylation of histones present at these growth genes to enable their activation (36) . Acetyl-CoA production increases during growth and enables the Gcn5p acetyltransferase present within SAGA to catalyze histone acetylation precisely at these genes. Because CLN3 is expressed at the same time as these other growth genes, it became predictable that CLN3 might also be regulated by acetyl-CoA-driven histone acetylation. We now show that this is indeed the case using two different but complementary culturing methods in the YMC and batch culture. Just like ribosomal and other growth genes, acetyl-CoA enables Gcn5p present within SAGA to catalyze the acetylation of histones present at the CLN3 regulatory region. Recruitment of SAGA to the CLN3 locus is dependent on the catalytic activity of Gcn5p, suggesting that the acetylation of particular subunits within SAGA (Spt7p, Ada3p, and Sgf73p), induced by acetyl-CoA, may be a key event that facilitates its recruitment to all of its growth gene targets. The role of SAGA and histone acetylation in mediating activation of CLN3 is further supported by a previous report showing that CLN3 mRNA levels are reduced in ada2 and ngg1 mutants within SAGA and derepressed in rpd3 histone deacetylase mutants (8) . It remains possible that acetyl-CoA could also indirectly promote transcription of CLN3 through additional mechanisms, for example via other downstream metabolites or via induction of glucose transporters expressed during growth (36) .
Because SAGA cannot bind DNA directly, it is most likely recruited to gene regulatory regions by transcription factors. Although Azf1p and Mcm1p are transcription factors that have been previously reported to regulate CLN3 transcription, we did not observe their binding to the CLN3 locus at the correct time of its activation in the YMC. By screening other transcription factors with potential binding sites in the CLN3 regulatory region, we observed that the ribosomal transcription factors Rap1p and Fhl1p also bound the CLN3 regulatory region at the correct time of its activation in the YMC as well as following glucose repletion. Moreover, a rap1-ts mutant at the nonpermissive temperature exhibited compromised CLN3 transcription (Fig. 5C) . Thus, these transcription factors may coordinate with SAGA to activate CLN3 in addition to ribosomal genes, in response to increased acetyl-CoA production. Because the binding of Azf1p and Mcm1p to CLN3 occurs subsequent to its activation in the YMC, these transcription factors may function as repressors to help maintain the gene in a silent state. Future work will be required to elucidate the role of these transcription factors in the regulation of CLN3 transcription.
Budding yeast cells accumulate substantial amounts of the storage carbohydrates trehalose and glycogen upon entry into stationary phase or quiescence (69, 70) . They then break down these carbohydrate stores to produce glucose, providing a "finishing kick" to Start for reentry into growth (70, 71) . In summary, our studies indicate that a key output of glucose metabolism critical for cell proliferation is an increase in acetyl-CoA production. Indeed, we observed that intracellular acetyl-CoA levels increase substantially during the OX growth phase of the YMC as well as in exponential growth, compared with the stationary phase (36) . The burst of acetyl-CoA production, most easily fueled by glucose, increases the acetylation rate of Gcn5p-containing SAGA, enabling it to acetylate histones at a set of more than 1,000 growth genes, as well as CLN3, leading to activation of these genes and thereby setting the cellular growth program in motion (Fig. 6) . Thus, acetyl-CoA may represent the metabolic basis of the elusive "finishing kick" and "size/growth rate threshold" (4) that gates entry into the Start of the cell-division cycle by regulating access to these growth genes in the chromatin. As such, our results strongly suggest that the very molecule that is used to stitch together cellular building blocks such as fatty acids, sterols, and amino acids is a critical metabolite that is monitored by yeast cells in the decision to proliferate.
Materials and Methods
The prototrophic CEN.PK strain background was used for all experiments. Multiple replicates were performed for all experiments. Experimental methods and yeast strains are provided in SI Materials and Methods.
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